Nathalie Clerget

Nathalie Clerget's work experience is as follows:

- VP Clinical Operations at Quell Therapeutics since January 2021.

- Senior VP Clinical Development and Regulatory at Promethera Biosciences from January 2020 to January 2021.

- VP Clinical Development at Promethera Biosciences from April 2019 to January 2020.

- Senior Director of Clinical Development at Promethera Biosciences from September 2018 to March 2019.

- Senior Director of Clinical Operations at TXCELL from May 2010 to August 2018.

- Clinical Project Manager at TXCELL from December 2007 to April 2010.

- Clinical Project Manager at IRIS PHARMA in 2007.

- Clinical QA and Regulatory at Iris Pharma (Clirophtha) from 2003 to 2006.

- ARC at Clirophtha- Iris Pharma from 2001 to 2003.

Nathalie Clerget obtained their Doctor of Philosophy (PhD) degree from Université Paris Cité in 2000. There is no information available regarding their education history prior to that. Additionally, there is mention of their affiliation with Hôpital Marie Lannelongue, but no specific degree or field of study is provided.